Dr. Patrick Soon-Shiong, founder of NantWorks, describes his vision for turning cancer into a chronic but controllable disease by using advanced rapid gene sequencing, supercomputing and other methods of analysis to transcend the genome to the proteome. This approach has the potential to redefine how cancer is diagnosed and to develop therapies precisely tailored to the molecular profile of a particular tumor. Dr. Soon-Shiong anticipates a revolution in drug research, development and delivery of molecularly designed cancer treatments to patients. (#25909)